SOPHiA GENETICS CLO sells 2,400 shares for taxes

SOPHiA GENETICS SA Chief Legal Officer Daan Van Well reported selling 2,400 Ordinary Shares of SOPH on April 10, 2026 at a weighted average price of $4.6672 per share.

Rhea-AI Filing Summary

SOPHiA GENETICS SA Chief Legal Officer Daan Van Well reported selling 2,400 Ordinary Shares of SOPH on April 10, 2026 at a weighted average price of $4.6672 per share. The footnotes state these shares were sold in the open market solely to satisfy tax withholding obligations from restricted stock units vesting on April 2 and 3, 2026.

The sales were executed under a pre-established Rule 10b5-1(c) trading plan and are described as non-discretionary. After the transaction, Van Well directly holds 346,420 Ordinary Shares, indicating he retained a substantial equity position in the company.

Insider Trade Summary 10b5-1

Net Seller: 2,400 shares

Net Sell 1 txn

Insider Van Well Daan

Role Chief Legal Officer

Sold 2,400 shs ($11K)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares	2,400	$4.6672	$11K

Holdings After Transaction: Ordinary Shares — 346,420 shares (Direct)

Footnotes (2)

1. F1. Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
2. F2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.61 to $4.77, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold: 2,400 shares Weighted average sale price: $4.6672 per share Post-transaction holdings: 346,420 shares +3 more

6 metrics

Shares sold 2,400 shares Ordinary Shares sold on April 10, 2026

Weighted average sale price $4.6672 per share Open-market sale on April 10, 2026

Post-transaction holdings 346,420 shares Ordinary Shares directly owned after sale

Sale price range $4.61–$4.77 per share Multiple transactions within reported range

Transaction type Open-market sale Code S, non-derivative Form 4 transaction

Plan type Rule 10b5-1(c) trading plan Pre-established plan governing these sales

Key Terms

Rule 10b5-1(c) trading plan, restricted stock units, weighted average price, open market

4 terms

Rule 10b5-1(c) trading plan regulatory

"These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person"

A Rule 10b5-1(c) trading plan is a legally defined, pre-set schedule that lets company insiders automatically buy or sell stock at specified times or under set formulas when they are not in possession of undisclosed, sensitive information. Think of it like an automatic payment plan for trades: because the instructions are written in advance, trades under the plan help protect insiders from allegations of trading on secret information and give investors clearer expectations about when insiders will transact, which can affect liquidity and perceived transparency.

restricted stock units financial

"tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

weighted average price financial

"The price reported in Column 4 is a weighted average price"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open market market

"Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations"

An open market is a system where buying and selling of goods, services, or financial assets happen freely without restrictions or special controls. For investors, it means they can trade assets easily and quickly, which helps determine fair prices based on supply and demand. This environment encourages transparency and competition, making it easier to buy or sell with confidence.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did SOPHiA GENETICS (SOPH) report for Daan Van Well?

SOPHiA GENETICS reported that Chief Legal Officer Daan Van Well sold 2,400 Ordinary Shares on April 10, 2026, at a weighted average price of $4.6672. The filing states the sale was to cover tax withholding on recently vested restricted stock units.

Why did SOPHiA GENETICS officer Daan Van Well sell 2,400 SOPH shares?

The filing explains that Daan Van Well sold 2,400 Ordinary Shares to satisfy tax withholding obligations arising from restricted stock units that vested on April 2 and 3, 2026. These sales are described as mechanistic rather than discretionary investment decisions.

Were Daan Van Well’s SOPH share sales made under a Rule 10b5-1 plan?

Yes. The footnotes state the April 10, 2026 share sales were executed under a pre-established Rule 10b5-1(c) trading plan adopted by Daan Van Well. This indicates the transactions were pre-planned and not timed at his discretion based on market conditions.

How many SOPH shares does Daan Van Well hold after this Form 4 sale?

After selling 2,400 Ordinary Shares, the Form 4 reports that Daan Van Well directly holds 346,420 SOPHiA GENETICS Ordinary Shares. This post-transaction balance shows he continues to maintain a significant ownership stake in the company following the tax-related sale.

What price range did Daan Van Well receive for the sold SOPH shares?

The reported weighted average sale price was $4.6672 per share. Footnotes clarify the 2,400 shares were sold in multiple transactions at prices ranging from $4.61 to $4.77, inclusive. Detailed trade-by-trade pricing is available upon written request to the company or regulators.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/14/2026 - 04:02 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Van Well Daan

(Last) (First) (Middle)

C/O SOPHIA GENETICS SA

LA PIECE 12

(Street)

ROLLE 1180

(City) (State) (Zip)

SWITZERLAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
SOPHiA GENETICS SA [ SOPH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	04/10/2026		S		2,400(1)	D	$4.6672(2)	346,420	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.

2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.61 to $4.77, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Elimara Brunetto as Attorney-in-Fact for Daan van Well	04/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)